Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
– Brings Together Eye Care and CRISPR Innovators to Develop Transformative Medicines for Patients – – Provides Allergan Exclusive Access to Multiple Editas Medicine Ocular Programs Based on its...
-
First to demonstrate single dose, in vivo results, showing approximately 97 percent reduction in serum transthyretin protein levelsFurther established a comprehensive platform, including a proprietary...
-
BASEL, Switzerland, CAMBRIDGE, Mass., and GAITHERSBURG, Md., March 14, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative...
-
Valmet Oyj:n lehdistötiedote 14.3.2017 klo 11:00 Valmet toimittaa automaation Rauma Marine Constructions -yhtiön (RMC) rakentamalle RoPax-alukselle, joka toimitetaan Mols-Linien -laivayhtiölle....
-
Valmet Oyj's press release on March 14, 2017 at 11:00 a.m. EET Valmet will supply automation for Mols-Linien's RoPax vessel built by Rauma Marine Constructions (RMC). The order was included in...
-
ATLANTA, March 13, 2017 (GLOBE NEWSWIRE) -- UPS (NYSE:UPS) today announced that it has been recognized by the Ethisphere® Institute as a World’s Most Ethical Company for the eleventh consecutive...
-
NEW YORK, March 13, 2017 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ:XELB) announced today that Judith Ripka, a luxury jewelry brand in its portfolio, is celebrating its 40th anniversary in...
-
WALTHAM, Mass., March 13, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
-
NEWTOWN, Pa., March 12, 2017 (GLOBE NEWSWIRE) -- With the potential impact of winter storm Stella on the East Coast, EPAM has made the decision to postpone its Investor & Analyst Day, originally...
-
BASEL, Switzerland and CAMBRIDGE, Mass., March 10, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics, (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...